January 13, 2020
Stocks To Watch This Week
Aclaris Therapeutics, Inc. ($ACRS) is a Biotechnology company in the Healthcare sector. This company had a significant gap up during pre-market on Friday morning. The company said the Phase 1 clinical trial ATI-450 resulted in marked inhibition of TNF-Alpha, IL1-Beta, IL8, and IL6, and was generally well-tolerated at all doses tested in the trial. “Aclaris said the trial also showed ATI-450 had dose-proportional pharmacokinetics with a terminal half-life of 9-12 hours, and had no meaningful food effect or drug-to-drug interaction with methotrexate.” I plan to day trade this over the $2.25 natural resistance level!
Want more picks like this? Visit our website for daily stock watch-lists!